Ekaterini Zapantis, MD
Basic profileDonald & Barbara Zucker School of Medicine at Hofstra/Northwell
Ekaterini Zapantis is a Rheumatology/Immunology physician affiliated with Donald & Barbara Zucker School of Medicine at Hofstra/Northwell. OpenAlex indexes 9 publications with 250 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2475 Harlem Rd
Cheektowaga, NY 142254558
Telephone
716-322-5428Registry record last updated 6 Jan 2016.
Industry payments
35 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202513 payments$14,328openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202510 payments
- PFIZER INC.Program year202525 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
40.1%Folate Analog Metabolic Inhibitor32.1%Methotrexate100%Part D≥19 patientsPhosphodiesterase 4 Inhibitor8%Otezla100%Part D<11 patientsMetabolism & gastrointestinal
35%Antidiarrheal microorganisms22.6%Folic Acid100%Part D<11 patientsAminosalicylate12.4%Sulfasalazine100%Part D<11 patientsAntiparasitic
24.8%Antimalarial24.8%Hydroxychloroquine Sulfate100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis
Seminars in Nephrology
2015 - THU0400 Response to Eculizumab in the Antiphospholipid Antibody Syndrome
Annals of the Rheumatic Diseases
2015 - A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult‐onset Still's disease: targeting <scp>IL</scp>‐6
International Journal of Rheumatic Diseases
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Henry Woo, MD
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
Azzour Hazzan, MD
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
Adiel Fleischer, MD
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
Shamir Hasan, DO
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”